2-TIP QANDLI DIABET RIVOJLANISHIDA INSULIN REZISTENTLIGINING ROLI VA ZAMONAVIY DAVOLASH USULLARI

Authors

  • Madaminov Dilshodbek Abdusattor o‘g‘li Fargona oltiariq Endokrinologiya yo’nalishi Ordinatura 1-kurs

Keywords:

2-tip qandli diabet, insulin rezistentligi, glyukoza almashinuvi, metformin, SGLT2 ingibitorlari, GLP-1 agonistlari, metabolik sindrom, semizlik.

Abstract

Mazkur ilmiy maqolada 2-tip qandli diabet rivojlanishida insulin rezistentligining patofiziologik mexanizmlari, uning metabolik buzilishlar bilan o‘zaro bog‘liqligi hamda kasallikni davolashda qo‘llanilayotgan zamonaviy yondashuvlar tahlil qilinadi. Insulin rezistentligi organizm hujayralarining insulin gormoniga sezuvchanligining pasayishi bilan tavsiflanadi va u glyukoza almashinuvi buzilishining asosiy omillaridan biri hisoblanadi. Tadqiqotlarda insulin rezistentligi semizlik, yallig‘lanish jarayonlari, genetik omillar va turmush tarzi bilan chambarchas bog‘liq ekanligi aniqlangan. Maqolada metformin, SGLT2 ingibitorlari, GLP-1 retseptor agonistlari kabi zamonaviy farmakologik vositalarning samaradorligi ham ilmiy manbalar asosida tahlil qilinadi.

References

International Diabetes Federation. IDF Diabetes Atlas. – Brussels: IDF, 2021. – 15–22-betlar.

DeFronzo R.A. Insulin resistance and diabetes. – Diabetes Care, 2009. – 173–180-betlar.

Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose metabolism. – Nature, 2001. – 799–806-betlar.

American Diabetes Association. Standards of Medical Care in Diabetes. – Diabetes Care, 2023. – 45–52-betlar.

World Health Organization. Global report on diabetes. – Geneva: WHO, 2016. – 30–41-betlar.

Shulman G.I. Cellular mechanisms of insulin resistance. – Journal of Clinical Investigation, 2000. – 171–176-betlar.

Kahn S.E., Hull R.L. Mechanisms linking obesity to insulin resistance. – Nature, 2006. – 840–846-betlar.

Taylor R. Pathogenesis of type 2 diabetes. – Lancet Diabetes & Endocrinology, 2013. – 149–156-betlar.

Rena G., Hardie D.G. The mechanisms of action of metformin. – Diabetologia, 2017. – 1577–1585-betlar.

Zinman B. et al. Empagliflozin cardiovascular outcomes trial. – New England Journal of Medicine, 2015. – 2117–2128-betlar.

Drucker D.J. Mechanisms of action of GLP-1 receptor agonists. – Cell Metabolism, 2018. – 740–756-betlar.

Wild S. Global prevalence of diabetes. – Diabetes Care, 2004. – 1047–1053-betlar.

Downloads

Published

2026-02-28

How to Cite

Madaminov Dilshodbek Abdusattor o‘g‘li. (2026). 2-TIP QANDLI DIABET RIVOJLANISHIDA INSULIN REZISTENTLIGINING ROLI VA ZAMONAVIY DAVOLASH USULLARI. IQRO , 20(01), 1451–1456. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/5603